Evidence map›Paper›PMID 26687682›Full record

ArticleMolecular cell2016

Two FGF Receptor Kinase Molecules Act in Concert to Recruit and Transphosphorylate Phospholipase Cγ.

Zhifeng Huang, William M Marsiglia, Upal Basu Roy, Nader Rahimi, Dariush Ilghari, Huiyan Wang, Huaibin Chen, Weiming Gai, Steven Blais, Thomas A Neubert and 4 more

Erratum issuedOpen access · bronzeAbstract read
In one paragraph

Article in Molecular cell, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 35 papers.

0numbers the graph read from it
0cells of the map it votes in
35citing papers in PubMed
1.1field-weighted citation impact, top 23% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

35 citing papers in PubMed, 57 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. FGF family in health and disease.Molecular biomedicine · 2026
    Review
  5. Article
  6. Article
  7. FGF-based drug discovery: advances and challenges.Nature reviews. Drug discovery · 2025
    Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Review
  14. Article
  15. Article
  16. Review
  17. Fibroblast growth factor receptor fusions in cancer: opportunities and challenges.Journal of experimental & clinical cancer research : CR · 2021
    Review
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

  • Erratum issued
5 · Who and what money

Authors and funding

14 authors at 3 institutions in 2 countries.

Zhifeng HuangSchool of Pharmacy, Wenzhou Medical University, Wenzhou, Zhejiang 325035, China; Department of Biochemistry & Molecular Pharmacology, New York University School of Medicine, New York, NY 10016, USA.
William M MarsigliaDepartment of Chemistry, New York University, New York, NY 10012, USA.
Upal Basu RoyDepartment of Microbiology, New York University School of Medicine, New York, NY 10016, USA.
Nader RahimiDepartment of Pathology and Laboratory of Medicine, Boston University School of Medicine, Boston, MA 02118, USA.
Dariush IlghariDepartment of Biochemistry & Molecular Pharmacology, New York University School of Medicine, New York, NY 10016, USA.
Huiyan WangSchool of Pharmacy, Wenzhou Medical University, Wenzhou, Zhejiang 325035, China; Department of Biochemistry & Molecular Pharmacology, New York University School of Medicine, New York, NY 10016, USA.
Huaibin ChenSchool of Pharmacy, Wenzhou Medical University, Wenzhou, Zhejiang 325035, China; Department of Biochemistry & Molecular Pharmacology, New York University School of Medicine, New York, NY 10016, USA.
Weiming GaiDepartment of Biochemistry & Molecular Pharmacology, New York University School of Medicine, New York, NY 10016, USA.
Steven BlaisSkirball Institute of Biomolecular Medicine, New York University School of Medicine, New York, NY 10016, USA.
Thomas A NeubertSkirball Institute of Biomolecular Medicine, New York University School of Medicine, New York, NY 10016, USA.
Alka MansukhaniDepartment of Microbiology, New York University School of Medicine, New York, NY 10016, USA.
Nathaniel J TraasethDepartment of Chemistry, New York University, New York, NY 10012, USA.
Xiaokun LiSchool of Pharmacy, Wenzhou Medical University, Wenzhou, Zhejiang 325035, China. Electronic address: xiaokunli@wzmu.edu.cn.
Moosa MohammadiDepartment of Biochemistry & Molecular Pharmacology, New York University School of Medicine, New York, NY 10016, USA. Electronic address: moosa.mohammadi@nyumc.org.
New York University · USWenzhou Medical University · CNBoston University · US

Funding

MECHANISMS OF FGF RECEPTOR REGULATION AND SIGNALINGR01DE013686 · NIDCR · NEW YORK UNIVERSITY SCHOOL OF MEDICINE · PI MOHAMMADI, MOOSA · 2000 to 2020
$12.3M
Protein Mass Spectrometry Core Facility for NeuroscienceP30NS050276 · NINDS · NEW YORK UNIVERSITY SCHOOL OF MEDICINE · PI NEUBERT, THOMAS A · 2005 to 2015
$7.9M
900 MHz NMR Spectrometer for Structural BiologyP41GM066354 · NIGMS · NEW YORK STRUCTURAL BIOLOGY CENTER · PI COWBURN, DAVID · 2002 to 2006
$4.7M
EXTRAMURAL RESEARCH FACILITIES CONSTRUCTIONC06RR015495 · NCRR · NEW YORK STRUCTURAL BIOLOGY CENTER · PI RIFKIND, RICHARD A · 2000 to 2000
$2.0M
Harnessing the Multipotency of Cancer Stem Cells for Differentiation TherapyR21CA186031 · NCI · NEW YORK UNIVERSITY SCHOOL OF MEDICINE · PI MANSUKHANI, ALKA · 2014 to 2015
$406k
Overcoming the resistance to anti-angiogenesis therapyR21CA191970 · NCI · BOSTON UNIVERSITY MEDICAL CAMPUS · PI RAHIMI, NADER · 2015 to 2016
$392k
IGPR-1 in colon cancer chemotherapyR21CA193958 · NCI · BOSTON UNIVERSITY MEDICAL CAMPUS · PI RAHIMI, NADER · 2015 to 2016
$392k
Acquisition of a Cryoprobe for a 600 MHz NMR SpectrometerS10OD016343 · OD · NEW YORK UNIVERSITY · PI KROGSGAARD, MICHELLE, TRAASETH, NATHANIEL J. · 2014 to 2014
$360k
NCI NIH HHS R21 CA186031NCI NIH HHS R21 CA191970NCI NIH HHS R21CA191970NCI NIH HHS R21 CA193958NCI NIH HHS R21CA193958NCRR NIH HHS C06 RR015495NCRR NIH HHS C06RR015495NIDCR NIH HHS DE13686NIDCR NIH HHS R01 DE013686NIGMS NIH HHS P41 GM066354NIGMS NIH HHS P41GM066354NIH HHS OD016343NIH HHS S10 OD016343NINDS NIH HHS P30 NS050276
6 · The paper itself

Abstract

The molecular basis by which receptor tyrosine kinases (RTKs) recruit and phosphorylate Src Homology 2 (SH2) domain-containing substrates has remained elusive. We used X-ray crystallography, NMR spectroscopy, and cell-based assays to demonstrate that recruitment and phosphorylation of Phospholipase Cγ (PLCγ), a prototypical SH2 containing substrate, by FGF receptors (FGFR) entails formation of an allosteric 2:1 FGFR-PLCγ complex. We show that the engagement of pTyr-binding pocket of the cSH2 domain of PLCγ by the phosphorylated tail of an FGFR kinase induces a conformational change at the region past the cSH2 core domain encompassing Tyr-771 and Tyr-783 to facilitate the binding/phosphorylation of these tyrosines by another FGFR kinase in trans. Our data overturn the current paradigm that recruitment and phosphorylation of substrates are carried out by the same RTK monomer in cis and disclose an obligatory role for receptor dimerization in substrate phosphorylation in addition to its canonical role in kinase activation.

Indexed as

Amino Acid SequenceBinding SitesCrystallography, X-RayErbB ReceptorsHEK293 CellsHumansHydrolysisModels, MolecularMolecular Sequence DataMultienzyme ComplexesNuclear Magnetic Resonance, BiomolecularPhosphatidylinositolsPhospholipase C gammaPhosphorylationProtein BindingProtein ConformationErbB ReceptorsFGFR1 protein, humanFGFR2 protein, humanMultienzyme ComplexesPhosphatidylinositolsPhospholipase C gammaphospholipase Cgamma1, ratPlcg1 protein, mouseReceptor, Fibroblast Growth Factor, Type 1Receptor, Fibroblast Growth Factor, Type 2Receptors, Platelet-Derived Growth FactorVascular Endothelial Growth Factor Receptor-2

Identifiers

PMID26687682
PMCPMC4838190
OpenAlexW2194755425

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.